Bionano Genomics Reports Third Quarter 2019 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/8/2026
- Wall St falls as Trump's Iran remarks weigh on markets
- Oil prices jump 7% as US-Iran truce buckles under fresh hostilities
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- Fiserv president resigns, interim leaders named for financial unit
- Nasdaq sinks as AI worries hit chipmakers
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- Amazon launches bond sale seeking at least $25 billion
BioNano Genomics, Inc. (BNGO) Q3 Revs Miss Views
November 7, 2019 4:16 PM ESTBioNano Genomics, Inc. (NASDAQ: BNGO) reported Q3 revenue of $3.3 million versus the consensus estimate of $4.44 million.
Data continue to confirm and validate Saphyrs potential to replace traditional cytogenetics methods for the detection of structural variants in certain blood cancers, and we are... More
